BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arun G, Diermeier SD, Spector DL. Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends Mol Med 2018;24:257-77. [PMID: 29449148 DOI: 10.1016/j.molmed.2018.01.001] [Cited by in Crossref: 317] [Cited by in F6Publishing: 340] [Article Influence: 63.4] [Reference Citation Analysis]
Number Citing Articles
1 Arman K, Dalloul Z, Bozgeyik E. Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics. Gene 2023;:147232. [PMID: 36736508 DOI: 10.1016/j.gene.2023.147232] [Reference Citation Analysis]
2 Pan H, Wei W, Fu G, Pan J, Jin B. LINC00941 Promotes Cell Malignant Behavior and Is One of Five Costimulatory Molecule-Related lncRNAs That Predict Prognosis in Renal Clear Cell Carcinoma. Medicina 2023;59:187. [DOI: 10.3390/medicina59020187] [Reference Citation Analysis]
3 Emami Meybodi SM, Soleimani N, Yari A, Javadifar A, Tollabi M, Karimi B, Emami Meybodi M, Seyedhossaini S, Brouki Milan P, Dehghani Firoozabadi A. Circulatory long noncoding RNAs (circulatory-LNC-RNAs) as novel biomarkers and therapeutic targets in cardiovascular diseases: Implications for cardiovascular diseases complications. Int J Biol Macromol 2023;225:1049-71. [PMID: 36414082 DOI: 10.1016/j.ijbiomac.2022.11.167] [Reference Citation Analysis]
4 Yeo SJ, Ying C, Fullwood MJ, Tergaonkar V. Emerging regulatory mechanisms of noncoding RNAs in topologically associating domains. Trends Genet 2023:S0168-9525(22)00312-2. [PMID: 36642680 DOI: 10.1016/j.tig.2022.12.003] [Reference Citation Analysis]
5 Zhou G, Fichorova RN, Holzman C, Chen B, Chang C, Kasten EP, Hoffmann HM. Placental circadian lincRNAs and spontaneous preterm birth. Front Genet 2022;13:1051396. [PMID: 36712876 DOI: 10.3389/fgene.2022.1051396] [Reference Citation Analysis]
6 Ansari S, Nikpour P. LNCAROD promotes the proliferation and migration of gastric cancer: a bioinformatics analysis and experimental validation. Funct Integr Genomics 2023;23:34. [PMID: 36625949 DOI: 10.1007/s10142-022-00954-5] [Reference Citation Analysis]
7 Sung WJ, Hong J. Targeting lncRNAs of colorectal cancers with natural products. Front Pharmacol 2022;13:1050032. [PMID: 36699052 DOI: 10.3389/fphar.2022.1050032] [Reference Citation Analysis]
8 Zhang J, Chen B, Fang X. 3D Structural Analysis of Long Noncoding RNA by Small Angle X-ray Scattering and Computational Modeling. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2687-0_10] [Reference Citation Analysis]
9 Siri G, Yazdani O, Esbati R, Akhavanfar R, Asadi F, Adili A, Ebrahimzadeh F, Hosseini SME. A comprehensive review of the role of lncRNAs in gastric cancer (GC) pathogenesis, immune regulation, and their clinical applications. Pathol Res Pract 2023;241:154221. [PMID: 36563559 DOI: 10.1016/j.prp.2022.154221] [Reference Citation Analysis]
10 Asadi M, Gholampour MA, Kompani F, Alizadeh S. Expression of Long Non-Coding RNA H19 in Acute Lymphoblastic Leukemia. Cell J 2023;25:1-10. [PMID: 36680478 DOI: 10.22074/cellj.2022.8315] [Reference Citation Analysis]
11 Lauer RC, Barry M, Smith TL, Thomas AM, Wu J, Du R, Lee JH, Rao A, Dobroff AS, Arap MA, Nunes DN, Silva IT, Dias-Neto E, Chen I, McCance DJ, Cavenee WK, Pasqualini R, Arap W. Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts. Elife 2023;12. [PMID: 36645410 DOI: 10.7554/eLife.81929] [Reference Citation Analysis]
12 Zhao M, Zhang Y, Shen S. A novel regulator in cancer initiation and progression: long noncoding RNA SHNG9. Clin Transl Oncol 2022. [PMID: 36586065 DOI: 10.1007/s12094-022-03060-x] [Reference Citation Analysis]
13 Mihanfar A, Yousefi B, Azizzadeh B, Majidinia M. Interactions of melatonin with various signaling pathways: implications for cancer therapy. Cancer Cell Int 2022;22:420. [PMID: 36581900 DOI: 10.1186/s12935-022-02825-2] [Reference Citation Analysis]
14 Liu X, Tuerxun H, Li Y, Li Y, He Y, Zhao Y. Ferroptosis: Reviewing CRC with the Third Eye. J Inflamm Res 2022;15:6801-12. [PMID: 36575747 DOI: 10.2147/JIR.S389290] [Reference Citation Analysis]
15 Su J, Deng L, Wang YD. Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer. Int J Mol Sci 2022;24. [PMID: 36613528 DOI: 10.3390/ijms24010089] [Reference Citation Analysis]
16 Yu AT, Aggarwal D, Pappin D, Spector DL. Single Oligonucleotide Capture of RNA And Temperature Elution Series ( SOCRATES ) for Identification of RNA-binding Proteins. Bio Protoc 2022;12:e4572. [PMID: 36618090 DOI: 10.21769/BioProtoc.4572] [Reference Citation Analysis]
17 Feng J, Tu R, Liu F, Zhang H, Dai Z, Wang Z, Luo P, Zhang J, Liu Z, Xiao G, Xia Z, Cheng Q. PD-L1-related LncRNAs are Associated with Immune Microenvironment and Prognosis in Glioma.. [DOI: 10.21203/rs.3.rs-2327559/v1] [Reference Citation Analysis]
18 Vancura A, Gutierrez AH, Hennig T, Pulido-Quetglas C, Slack FJ, Johnson R, Haefliger S. Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3. Noncoding RNA 2022;8. [PMID: 36548181 DOI: 10.3390/ncrna8060082] [Reference Citation Analysis]
19 Kannampuzha S, Ravichandran M, Mukherjee AG, Wanjari UR, Renu K, Vellingiri B, Iyer M, Dey A, George A, Gopalakrishnan AV. The mechanism of action of non-coding RNAs in placental disorders. Biomedicine & Pharmacotherapy 2022;156:113964. [DOI: 10.1016/j.biopha.2022.113964] [Reference Citation Analysis]
20 Wang Z, Chen J, Sun F, Zhao X, Dong Y, Yu S, Li J, Liang H. LncRNA CRLM1 inhibits apoptosis and promotes metastasis through transcriptional regulation cooperated with hnRNPK in colorectal cancer. Cell Biosci 2022;12:120. [DOI: 10.1186/s13578-022-00849-9] [Reference Citation Analysis]
21 Zhou Z, Cao Q, Diao Y, Wang Y, Long L, Wang S, Li P. Non-coding RNA-related antitumor mechanisms of marine-derived agents. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1053556] [Reference Citation Analysis]
22 Meng Q, Wang J, Jiang B, Zhang X, Xu J, Cao Y, Yang H, Wu S, Gao N, Zhang Y, Xu J, Chen H, Li X, Chen R. SiRNA-based delivery nanoplatform attenuates the CRC progression via HIF1α-AS2. Nano Today 2022;47:101667. [DOI: 10.1016/j.nantod.2022.101667] [Reference Citation Analysis]
23 Porman AM, Roberts JT, Duncan ED, Chrupcala ML, Levine AA, Kennedy MA, Williams MM, Richer JK, Johnson AM. A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells. PLoS Biol 2022;20:e3001885. [PMID: 36441764 DOI: 10.1371/journal.pbio.3001885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu T, Zhao H. Long Non-Coding RNAs: A Double-Edged Sword in Renal Cell Carcinoma Carcinogenesis. International J of Pharmacology 2022;18:1537-1549. [DOI: 10.3923/ijp.2022.1537.1549] [Reference Citation Analysis]
25 Kerachian MA, Azghandi M. Identification of long non-coding RNA using single nucleotide epimutation analysis: a novel gene discovery approach. Cancer Cell Int 2022;22:337. [DOI: 10.1186/s12935-022-02752-2] [Reference Citation Analysis]
26 Lauer RC, Barry M, Smith TL, Thomas AM, Wu J, Du R, Lee J, Rao A, Dobroff AS, Arap MA, Nunes DN, Silva IT, Dias-neto E, Chen I, Mccance DJ, Cavenee WK, Pasqualini R, Arap W. Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts.. [DOI: 10.1101/2022.10.25.22281522] [Reference Citation Analysis]
27 Feng Y, Li B, Wang K, Li X, Zhang L, Dong X. Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma. Front Mol Biosci 2022;9:977280. [DOI: 10.3389/fmolb.2022.977280] [Reference Citation Analysis]
28 Zhao Y, Dhani S, Zhivotovsky B. Unveiling caspase-2 regulation by non-coding RNAs. Cell Death Dis 2022;13:834. [PMID: 36171196 DOI: 10.1038/s41419-022-05270-1] [Reference Citation Analysis]
29 Li K, Feng Z, Qin K, Ma Y, Zhao S, Chen P, Lin J, Jiang Y, Han L, Cao Y, Luo J, Shi M, Chen H, Wang J, Jiang L, Peng C. LINC01137 facilitate pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis.. [DOI: 10.21203/rs.3.rs-2065916/v1] [Reference Citation Analysis]
30 Wang HQ, Qian CH, Guo ZY, Li PM, Qiu ZJ. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression via targeting miR-299-3p. World J Gastroenterol 2022; 28(35): 5141-5153 [DOI: 10.3748/wjg.v28.i35.5141] [Reference Citation Analysis]
31 Louca M, Gkretsi V. LincRNAs and snoRNAs in Breast Cancer Cell Metastasis: The Unknown Players. Cancers (Basel) 2022;14:4528. [PMID: 36139687 DOI: 10.3390/cancers14184528] [Reference Citation Analysis]
32 He J, Wu W. A glimpse of research cores and frontiers on the relationship between long noncoding RNAs (lncRNAs) and colorectal cancer (CRC) using the VOSviewer tool. Scand J Gastroenterol 2022;:1-10. [PMID: 36121831 DOI: 10.1080/00365521.2022.2124537] [Reference Citation Analysis]
33 Changizian M, Nourisanami F, Hajpoor V, Parvaresh M, Bahri Z, Motovali-Bashi M. LINC00467: A key oncogenic long non-coding RNA. Clin Chim Acta 2022;536:112-25. [PMID: 36122666 DOI: 10.1016/j.cca.2022.09.013] [Reference Citation Analysis]
34 Vancura A, Gutierrez AH, Hennig T, Pulido-quetglas C, Slack F, Johnson R, Häfliger S. Is evolutionary conservation a useful predictor for cancer long noncoding RNAs? Insights from the Cancer lncRNA Census 3.. [DOI: 10.1101/2022.09.01.506261] [Reference Citation Analysis]
35 Eptaminitaki GC, Stellas D, Bonavida B, Baritaki S. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 2022;65:100866. [DOI: 10.1016/j.drup.2022.100866] [Reference Citation Analysis]
36 Gan X, Ding D, Wang M, Yang Y, Sun D, Li W, Ding W, Yang F, Zhou W, Yuan S. DANCR deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient-derived xenograft in situ hepatoma mice model. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215930] [Reference Citation Analysis]
37 Fan N, Fu H, Feng X, Chen Y, Wang J, Wu Y, Bian Y, Li Y. Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. Front Mol Biosci 2022;9:941653. [DOI: 10.3389/fmolb.2022.941653] [Reference Citation Analysis]
38 Rashedi S, Mardani M, Rafati A, Khavandi MM, Mohammadi F, Javanshir S, Sarallah R, Dolatshahi M, Sabahi M, Azadnajafabad S, Tavolinejad H, Rezaei N. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma. J Clin Lab Anal 2022;:e24670. [PMID: 35989533 DOI: 10.1002/jcla.24670] [Reference Citation Analysis]
39 Wang Q, Chen C, Xu X, Shu C, Cao C, Wang Z, Fu Y, Xu L, Xu K, Xu J, Xia A, Wang B, Xu G, Zou X, Su R, Kang W, Xue Y, Mo R, Sun B, Wang S. APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly. Adv Sci (Weinh) 2022;:e2201889. [PMID: 35975461 DOI: 10.1002/advs.202201889] [Reference Citation Analysis]
40 Zhang Z, Wang X, Wang Y, Zhou D, Wu H, Cheng W, Wang Q, Zheng G, Wang J, Gu J. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5-fluorouracil of breast cancer cells through microRNA-145 meditated by p53. J Biochem Mol Toxicol 2022;:e23176. [PMID: 35968984 DOI: 10.1002/jbt.23176] [Reference Citation Analysis]
41 Anwar S, Shahwan M, Hasan GM, Islam A, Hassan MI. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy. Cell Signal 2022;99:110434. [PMID: 35961526 DOI: 10.1016/j.cellsig.2022.110434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Jones AN, Gabel F, Bohn S, Wolfe G, Sattler M. Cotranscriptional folding of the lncRNA Xist A-repeats indicates a modular structure.. [DOI: 10.1101/2022.07.26.501616] [Reference Citation Analysis]
43 Swati, Sharma V. The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology. Mol Biol Rep. [DOI: 10.1007/s11033-022-07770-x] [Reference Citation Analysis]
44 Zhang J, Li S, Zhang J, Zhang W, Jiang J, Wu H, Wu E, Feng Y, Yang L, Li Z. Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway. Cancer Lett 2022;545:215829. [PMID: 35868534 DOI: 10.1016/j.canlet.2022.215829] [Reference Citation Analysis]
45 Tabury K, Monavarian M, Listik E, Shelton AK, Choi AS, Quintens R, Arend RC, Hempel N, Miller CR, Györrfy B, Mythreye K. PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance. Life Sci Alliance 2022;5. [PMID: 35820706 DOI: 10.26508/lsa.202201370] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Samadian M. A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression. Cancer Cell Int 2022;22:225. [PMID: 35790972 DOI: 10.1186/s12935-022-02644-5] [Reference Citation Analysis]
47 Song Y, Chu P, Li P, Li F, Tang M. Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/1418232] [Reference Citation Analysis]
48 Islam S, Mukherjee C. Molecular regulation of hypoxia through the lenses of noncoding RNAs and epitranscriptome. WIREs RNA 2022. [DOI: 10.1002/wrna.1750] [Reference Citation Analysis]
49 Zhang L, Ding D, Liu J, Liu J, Wang N, Liu J. Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer. Medicine (Baltimore) 2022;101:e29759. [PMID: 35776987 DOI: 10.1097/MD.0000000000029759] [Reference Citation Analysis]
50 Fang Y, Pan X, Shen H. Recent Deep Learning Methodology Development for RNA–RNA Interaction Prediction. Symmetry 2022;14:1302. [DOI: 10.3390/sym14071302] [Reference Citation Analysis]
51 Qiao Y, Wang B, Yan Y, Niu L. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway. Environ Toxicol 2022. [PMID: 35730485 DOI: 10.1002/tox.23605] [Reference Citation Analysis]
52 Sargazi ML, Jafarinejad-Farsangi S, Moazzam-Jazi M, Rostamzadeh F, Karam ZM. The crosstalk between long non-coding RNAs and the hedgehog signaling pathway in cancer. Med Oncol 2022;39:127. [PMID: 35716241 DOI: 10.1007/s12032-022-01710-2] [Reference Citation Analysis]
53 Zhou Z, Wang Z, Gao J, Lin Z, Wang Y, Shan P, Li M, Zhou T, Li P. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma. Mol Ther Oncolytics 2022;25:98-120. [PMID: 35506150 DOI: 10.1016/j.omto.2022.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Vahabi A, Rezaie J, Hassanpour M, Panahi Y, Nemati M, Rasmi Y, Nemati M. Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities. Biochemical Pharmacology 2022;200:115038. [DOI: 10.1016/j.bcp.2022.115038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
55 Li J, Shi D, Wang L, Wu G. Chronic neuroinflammation regulates cAMP response element-binding protein in the formation of drug-resistant epilepsy by activating glial cells. Journal of Neurorestoratology 2022;10:100006. [DOI: 10.1016/j.jnrt.2022.100006] [Reference Citation Analysis]
56 Peñailillo R, Monteiro LJ, Acuña-gallardo S, García F, Velásquez V, Correa P, Díaz P, Valdebenito PP, Navarro C, Romero R, Sánchez M, Illanes SE, Nardocci G. Identification of LOC101927355 as a Novel Biomarker for Preeclampsia. Biomedicines 2022;10:1253. [DOI: 10.3390/biomedicines10061253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Zhu Y, Liu X, Wang Y, Pan Y, Han X, Peng B, Zhang X, Niu S, Wang H, Ye Q, Gu Y, Gao S. DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma. Cell Death Dis 2022;13:456. [PMID: 35562342 DOI: 10.1038/s41419-022-04898-3] [Reference Citation Analysis]
58 Yin X, Lin H, Lin L, Miao L, He J, Zhuo Z. LncRNAs and CircRNAs in cancer. MedComm 2022;3. [DOI: 10.1002/mco2.141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Lu W, Liu H, Zhang X, Guo Y, Liu L, Guo T, Qu L, Yang S, Li Z. A ceRNA Network Composed of Survival-Related lncRNAs, miRNAs, and mRNAs in Clear Cell Renal Carcinoma. Comput Math Methods Med 2022;2022:8504441. [PMID: 35529267 DOI: 10.1155/2022/8504441] [Reference Citation Analysis]
60 Zhong W, Qu H, Yao B, Wang D, Qiu J. Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer. Cureus. [DOI: 10.7759/cureus.24818] [Reference Citation Analysis]
61 Ma Q, Yang L, Tolentino K, Zhao Y, Lizenburger UM, Shi Q, Zhu L, Tsai M, Chen J, Lai I, Zeng H, Li L, Chang HY. Inducible lncRNA transgenic mice reveal continual role of HOTAIR in promoting breast cancer metastasis.. [DOI: 10.1101/2022.04.21.488980] [Reference Citation Analysis]
62 Shen B, Ding H, Ye Y, Luo B, Ding X. Role of the Long Intergenic Non-Protein-Coding RNA 1278/miR-185-5p/Cystatin SN Axis in Laryngeal Cancer Cells. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/6406943] [Reference Citation Analysis]
63 Coutinho de Almeida R, Tuerlings M, Ramos Y, Den Hollander W, Suchiman E, Lakenberg N, Nelissen R(, Mei H, Meulenbelt I. Allelic expression imbalance in articular cartilage and subchondral bone refined genome-wide association signals in osteoarthritis.. [DOI: 10.1101/2022.04.07.22273552] [Reference Citation Analysis]
64 Mathew S, Sivasubbu S. Long Non Coding RNA Based Regulation of Cerebrovascular Endothelium. Front Genet 2022;13:834367. [PMID: 35495157 DOI: 10.3389/fgene.2022.834367] [Reference Citation Analysis]
65 Shaalan AAM, Mokhtar SH, Ahmedah HT, Almars AI, Toraih EA, Ibrahiem AT, Fawzy MS, Salem MA. Prognostic Value of LINC-ROR (rs1942347) Variant in Patients with Colon Cancer Harboring BRAF Mutation: A Propensity Score-Matched Analysis. Biomolecules 2022;12:569. [DOI: 10.3390/biom12040569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Guo Y, Xie Y, Luo Y. The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment. Front Immunol 2022;13:851004. [PMID: 35222443 DOI: 10.3389/fimmu.2022.851004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
67 Aryee DNT, Fock V, Kapoor U, Radic-sarikas B, Kovar H. Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis. Cells 2022;11:1267. [DOI: 10.3390/cells11081267] [Reference Citation Analysis]
68 Jiang B, Liu Q, Gai J, Guan J, Li Q. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle. Immunopharmacol Immunotoxicol 2022;:1-18. [PMID: 35316129 DOI: 10.1080/08923973.2022.2056482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Wang F, Zhu L, Xue Q, Tang C, Tang W, Zhang N, Dai C, Chen Z. Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression. Oxid Med Cell Longev 2022;2022:1125932. [PMID: 35035655 DOI: 10.1155/2022/1125932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Nukala SB, Jousma J, Cho Y, Lee WH, Ong SG. Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology. Cell Biosci 2022;12:24. [PMID: 35246252 DOI: 10.1186/s13578-022-00757-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
71 Felix R, Muñoz-Herrera D, Corzo-López A, Fernández-Gallardo M, Leyva-Leyva M, González-Ramírez R, Sandoval A. Ion channel long non-coding RNAs in neuropathic pain. Pflugers Arch 2022. [PMID: 35235008 DOI: 10.1007/s00424-022-02675-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Fan B, Zhang Q, Wang N, Wang G. LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells. Front Oncol 2022;12:811374. [PMID: 35155247 DOI: 10.3389/fonc.2022.811374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Cole N, Lee P, Schwarz T, Zhang P, Freedman ML, Gusev A, Lindström S, Gandal MJ, Pasaniuc B, Bhattacharya A. Distal gene regulation mediated by non-coding RNAs contributes to germline risk for breast and prostate cancer.. [DOI: 10.1101/2022.02.08.22270601] [Reference Citation Analysis]
74 Melixetian M, Pelicci PG, Lanfrancone L. Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process. Cells 2022;11:577. [PMID: 35159386 DOI: 10.3390/cells11030577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
75 Sasa GBK, Xuan C, Chen M, Jiang Z, Ding X. Clinicopathological implications of lncRNAs, immunotherapy and DNA methylation in lung squamous cell carcinoma: a narrative review. Transl Cancer Res 2021;10:5406-29. [PMID: 35116387 DOI: 10.21037/tcr-21-1607] [Reference Citation Analysis]
76 Tabury K, Monavarian M, Listik E, Shelton AK, Choi AS, Quintens R, Arend R, Hempel N, Miller CR, Györrfy B, Mythreye K. PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistance.. [DOI: 10.1101/2022.01.11.475893] [Reference Citation Analysis]
77 Søndergaard JN, Sommerauer C, Atanasoai I, Hinte LC, Geng K, Guiducci G, Bräutigam L, Aouadi M, Stojic L, Barragan I, Kutter C. CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism. Gut 2022;71:2081-92. [PMID: 35022268 DOI: 10.1136/gutjnl-2021-325109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
78 He G, Qiu J, Liu C, Tian B, Cai D, Liu S. MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis. Front Oncol 2021;11:625566. [PMID: 35004265 DOI: 10.3389/fonc.2021.625566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Yao H, Tian L, Yan B, Yang L, Li Y. LncRNA TP73-AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes. Cancer Cell Int 2022;22:16. [PMID: 35012518 DOI: 10.1186/s12935-021-02418-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
80 Nacarkahya G, Horozoğlu C. Kolorektal kanserde lncRNA DPP10-AS1 ekspresyonu tümör baskılayıcı ve tümör mikroçevresinde metabolit transportuyla ilişkili olabilir mi? Akademik Gastroenteroloji Dergisi 2022. [DOI: 10.17941/agd.974118] [Reference Citation Analysis]
81 Zhang Y, Zhou M, Li K. MicroRNA-30 inhibits the growth of human ovarian cancer cells by suppressing RAB32 expression. Int J Immunopathol Pharmacol 2022;36:20587384211058642. [PMID: 34986662 DOI: 10.1177/20587384211058642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Wang X, Zhang H, Yin S, Yang Y, Yang H, Yang J, Zhou Z, Li S, Ying G, Ba Y. lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin. EMBO Rep 2022;23:e53140. [PMID: 34779552 DOI: 10.15252/embr.202153140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
83 李 伟. LINC00511 Regulates miRNAs to Promote Cancer Progression. ACM 2022;12:6953-6962. [DOI: 10.12677/acm.2022.1271002] [Reference Citation Analysis]
84 Ghosh S, Samanta A, Prasad P, Sinha D. Therapeutic Implications of Long Non-coding RNA in the Regulation of Lung Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_70] [Reference Citation Analysis]
85 Zocchi S, David A, Goodhardt M, Garrick D. Applications of noncoding ribonucleic acids in multiple myeloma patients. Clinical Applications of Non-Coding RNAs in Cancer 2022. [DOI: 10.1016/b978-0-12-824550-7.00005-9] [Reference Citation Analysis]
86 Ma Q, Yang L, Tolentino K, Wang G, Zhao Y, Litzenburger UM, Shi Q, Zhu L, Yang C, Jiao H, Zhang F, Li R, Tsai MC, Chen JA, Lai I, Zeng H, Li L, Chang HY. Inducible lncRNA transgenic mice reveal continual role of HOTAIR in promoting breast cancer metastasis. Elife 2022;11. [PMID: 36579891 DOI: 10.7554/eLife.79126] [Reference Citation Analysis]
87 Cadoni E, Pennati F, Muangkaew P, Elskens J, Madder A, Manicardi A. Synthesis and structure–activity relationship of peptide nucleic acid probes with improved interstrand-crosslinking abilities: application to biotin-mediated RNA-pulldown. RSC Chem Biol 2022;3:1129-1143. [DOI: 10.1039/d2cb00095d] [Reference Citation Analysis]
88 Kerachian MA. Noncoding RNAs in patients with colorectal cancer. Clinical Applications of Non-Coding RNAs in Cancer 2022. [DOI: 10.1016/b978-0-12-824550-7.00004-7] [Reference Citation Analysis]
89 Ruiz-Manriquez LM, Estrada-Meza C, Benavides-Aguilar JA, Ledesma-Pacheco SJ, Torres-Copado A, Serrano-Cano FI, Bandyopadhyay A, Pathak S, Chakraborty S, Srivastava A, Sharma A, Paul S. Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy. Phytother Res 2021. [PMID: 34932245 DOI: 10.1002/ptr.7338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
90 Janaththani P, Srinivasan SL, Batra J. Long Non-Coding RNAs at the Chromosomal Risk Loci Identified by Prostate and Breast Cancer GWAS. Genes (Basel) 2021;12:2028. [PMID: 34946977 DOI: 10.3390/genes12122028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Li Z, Li M, Xia P, Wang L, Lu Z. LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis. Cancer Manag Res 2021;13:9037-48. [PMID: 34916848 DOI: 10.2147/CMAR.S324920] [Reference Citation Analysis]
92 Sabaie H, Amirinejad N, Asadi MR, Jalaiei A, Daneshmandpour Y, Rezaei O, Taheri M, Rezazadeh M. Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer's Disease: A Systematic Scoping Review. Front Aging Neurosci 2021;13:742242. [PMID: 34899268 DOI: 10.3389/fnagi.2021.742242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
93 Hanssen KM, Haber M, Fletcher JI. Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition. Drug Resist Updat 2021;:100795. [PMID: 34983733 DOI: 10.1016/j.drup.2021.100795] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
94 Ren G, Xu L, Zhao J, Shao Y, Lu T, Zhang Q. Comparative transcriptome analysis of long non coding RNA (lncRNA) in RTG-2 cells infected by infectious hematopoietic necrosis virus. Fish Shellfish Immunol 2021;120:314-24. [PMID: 34890776 DOI: 10.1016/j.fsi.2021.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
95 Xu M, Cui R, Ye L, Wang Y, Wang X, Zhang Q, Wang K, Dong C, Le W, Chen B. LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Mol Ther Nucleic Acids 2021;26:280-94. [PMID: 34513310 DOI: 10.1016/j.omtn.2021.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
96 Naz F, Tariq I, Ali S, Somaida A, Preis E, Bakowsky U. The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers. Cancers (Basel) 2021;13:6102. [PMID: 34885213 DOI: 10.3390/cancers13236102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Wang N, Li J, Xin Q, Xu N. USP30-AS1 contributes to mitochondrial quality control in glioblastoma cells. Biochem Biophys Res Commun 2021;581:31-7. [PMID: 34653676 DOI: 10.1016/j.bbrc.2021.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
98 Banerjee R, Smith J, Eccles MR, Weeks RJ, Chatterjee A. Epigenetic basis and targeting of cancer metastasis. Trends in Cancer 2021. [DOI: 10.1016/j.trecan.2021.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Sheykhhasan M, Ahmadyousefi Y, Seyedebrahimi R, Tanzadehpanah H, Manoochehri H, Dama P, Hosseini NF, Akbari M, Eslami Farsani M. DLX6-AS1: a putative lncRNA candidate in multiple human cancers. Expert Rev Mol Med 2021;23:e17. [PMID: 34823630 DOI: 10.1017/erm.2021.17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
100 Eptaminitaki GC, Wolff N, Stellas D, Sifakis K, Baritaki S. Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy. Cells 2021;10:3313. [PMID: 34943820 DOI: 10.3390/cells10123313] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
101 Morgan R, da Silveira WA, Kelly RC, Overton I, Allott EH, Hardiman G. Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations. Expert Rev Mol Diagn 2021;:1-15. [PMID: 34666586 DOI: 10.1080/14737159.2021.1996227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
102 Chen D, Ping S, Xu Y, Wang M, Jiang X, Xiong L, Zhang L, Yu H, Xiong Z. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications. Front Cell Dev Biol 2021;9:732036. [PMID: 34805143 DOI: 10.3389/fcell.2021.732036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
103 Ghafouri-Fard S, Fathi M, Zhai T, Taheri M, Dong P. LncRNAs: Novel Biomarkers for Pancreatic Cancer. Biomolecules 2021;11:1665. [PMID: 34827663 DOI: 10.3390/biom11111665] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
104 Bardhan A, Banerjee A, Basu K, Pal DK, Ghosh A. PRNCR1: a long non-coding RNA with a pivotal oncogenic role in cancer. Hum Genet 2021. [PMID: 34727260 DOI: 10.1007/s00439-021-02396-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
105 Qin Q, Yang H, Zhang C, Han X, Guo J, Fan Z, Guo J. lncRNA HHIP-AS1 Promotes the Osteogenic Differentiation Potential and Inhibits the Migration Ability of Periodontal Ligament Stem Cells. Stem Cells Int 2021;2021:5595580. [PMID: 34721591 DOI: 10.1155/2021/5595580] [Reference Citation Analysis]
106 Xia Y, Wang WC, Shen WH, Xu K, Hu YY, Han GH, Liu YB. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Chem Biol Interact 2021;349:109652. [PMID: 34520751 DOI: 10.1016/j.cbi.2021.109652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
107 Waters E, Pucci P, Hirst M, Chapman S, Wang Y, Crea F, Heath CJ. HAR1: an insight into lncRNA genetic evolution. Epigenomics 2021;13:1831-43. [PMID: 34676772 DOI: 10.2217/epi-2021-0069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
108 Chen X, Chen Z, Wu H, Liu X, Nie F, Wang Z, Sun M. Comprehensive Genomic Characterization Analysis Identifies an Oncogenic Pseudogene RP11-3543B.1 in Human Gastric Cancer. Front Cell Dev Biol 2021;9:743652. [PMID: 34660601 DOI: 10.3389/fcell.2021.743652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
109 Winkler L, Dimitrova N. A mechanistic view of long noncoding RNAs in cancer. Wiley Interdiscip Rev RNA 2021;:e1699. [PMID: 34668345 DOI: 10.1002/wrna.1699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
110 Al-Harazi O, Kaya IH, Al-Eid M, Alfantoukh L, Al Zahrani AS, Al Sebayel M, Kaya N, Colak D. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses. Front Genet 2021;12:710049. [PMID: 34659334 DOI: 10.3389/fgene.2021.710049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Takeiwa T, Mitobe Y, Ikeda K, Hasegawa K, Horie K, Inoue S. Long Intergenic Noncoding RNA OIN1 Promotes Ovarian Cancer Growth by Modulating Apoptosis-Related Gene Expression. Int J Mol Sci 2021;22:11242. [PMID: 34681900 DOI: 10.3390/ijms222011242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
112 Zhao N, Zhang J, Zhao Q, Chen C, Wang H. Mechanisms of Long Non-Coding RNAs in Biological Characteristics and Aerobic Glycolysis of Glioma. Int J Mol Sci 2021;22:11197. [PMID: 34681857 DOI: 10.3390/ijms222011197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
113 Peng PH, Hsu KW, Chieh-Yu Lai J, Wu KJ. The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis. Biomed J 2021;44:521-33. [PMID: 34654684 DOI: 10.1016/j.bj.2021.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
114 Connerty P, Moles E, de Bock CE, Jayatilleke N, Smith JL, Meshinchi S, Mayoh C, Kavallaris M, Lock RB. Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia. Pharmaceutics 2021;13:1681. [PMID: 34683974 DOI: 10.3390/pharmaceutics13101681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
115 Hatanaka Y, Niinuma T, Kitajima H, Nishiyama K, Maruyama R, Ishiguro K, Toyota M, Yamamoto E, Kai M, Yorozu A, Sekiguchi S, Ogi K, Dehari H, Idogawa M, Sasaki Y, Tokino T, Miyazaki A, Suzuki H. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes. Sci Rep 2021;11:20438. [PMID: 34650128 DOI: 10.1038/s41598-021-99736-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Sabol M, Calleja-Agius J, Di Fiore R, Suleiman S, Ozcan S, Ward MP, Ozretić P. (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers. Cancers (Basel) 2021;13:5040. [PMID: 34680193 DOI: 10.3390/cancers13205040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Ou C, He X, Liu Y, Zhang X. lncRNA cytoskeleton regulator RNA (CYTOR): Diverse functions in metabolism, inflammation and tumorigenesis, and potential applications in precision oncology. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.08.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Wu C, Bian X, Zhang L, Hu Y, Wu Y, Pei T, Han X. Long noncoding RNA LINC00968 inhibits proliferation, migration and invasion of lung adenocarcinoma through targeting miR-22-5p/CDC14A axis. 3 Biotech 2021;11:433. [PMID: 34603911 DOI: 10.1007/s13205-021-02981-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
119 Wang X, Parodi L, Hawkins SM. Translational Applications of Linear and Circular Long Noncoding RNAs in Endometriosis. Int J Mol Sci 2021;22:10626. [PMID: 34638965 DOI: 10.3390/ijms221910626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting Drug Chemo-Resistance in Cancer Using Natural Products. Biomedicines 2021;9:1353. [PMID: 34680470 DOI: 10.3390/biomedicines9101353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
121 Wozniak M, Czyz M. The Functional Role of Long Non-Coding RNAs in Melanoma. Cancers (Basel) 2021;13:4848. [PMID: 34638331 DOI: 10.3390/cancers13194848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
122 Jia H, Liu Y, Lv S, Qiao R, Zhang X, Niu F, Shang W, Liu S, Dong J, Zhang Z. LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2. Front Mol Biosci 2021;8:706570. [PMID: 34552959 DOI: 10.3389/fmolb.2021.706570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
123 Hegre SA, Samdal H, Klima A, Stovner EB, Nørsett KG, Liabakk NB, Olsen LC, Chawla K, Aas PA, Sætrom P. Joint changes in RNA, RNA polymerase II, and promoter activity through the cell cycle identify non-coding RNAs involved in proliferation. Sci Rep 2021;11:18952. [PMID: 34556693 DOI: 10.1038/s41598-021-97909-w] [Reference Citation Analysis]
124 Wang X, Liu H, Zhang Q, Zhang X, Qin Y, Zhu G, Dang J, Wang F, Yang X, Fan R. LINC00514 promotes lipogenesis and tumor progression in esophageal squamous cell carcinoma by sponging miR‑378a‑5p to enhance SPHK1 expression. Int J Oncol 2021;59:86. [PMID: 34533201 DOI: 10.3892/ijo.2021.5266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Pulido-Quetglas C, Johnson R. Designing libraries for pooled CRISPR functional screens of long noncoding RNAs. Mamm Genome 2021. [PMID: 34533605 DOI: 10.1007/s00335-021-09918-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Yadav G, Kulshreshtha R. Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targets. J Cell Physiol 2021. [PMID: 34533835 DOI: 10.1002/jcp.30577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
127 Liu QL, Zhang Z, Wei X, Zhou ZG. Noncoding RNAs in tumor metastasis: molecular and clinical perspectives. Cell Mol Life Sci 2021;78:6823-50. [PMID: 34499209 DOI: 10.1007/s00018-021-03929-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
128 Taiana E, Favasuli V, Ronchetti D, Morelli E, Tassone P, Viglietto G, Munshi NC, Neri A, Amodio N. In Vitro Silencing of lncRNAs Using LNA GapmeRs. Methods Mol Biol 2021;2348:157-66. [PMID: 34160805 DOI: 10.1007/978-1-0716-1581-2_10] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
129 Deng Y, Li K, Tan F, Liu H. Gene Model Related to m6A Predicts the Prognostic Effect of Immune Infiltration on Head and Neck Squamous Cell Carcinoma. J Oncol 2021;2021:1814266. [PMID: 34457003 DOI: 10.1155/2021/1814266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Shahzadi SK, Naidoo N, Alsheikh-Ali A, Rizzo M, Rizvi AA, Santos RD, Banerjee Y. Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review. Int J Mol Sci 2021;22:9378. [PMID: 34502285 DOI: 10.3390/ijms22179378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Hussen BM, Azimi T, Abak A, Hidayat HJ, Taheri M, Ghafouri-Fard S. Role of lncRNA BANCR in Human Cancers: An Updated Review. Front Cell Dev Biol 2021;9:689992. [PMID: 34409032 DOI: 10.3389/fcell.2021.689992] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
132 Guo H, Li C, Su X, Huang X. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Genet Test Mol Biomarkers 2021;25:517-27. [PMID: 34406843 DOI: 10.1089/gtmb.2021.0066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Barik GK, Sahay O, Behera A, Naik D, Kalita B. Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application. Biochim Biophys Acta Rev Cancer 2021;1876:188612. [PMID: 34391844 DOI: 10.1016/j.bbcan.2021.188612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
134 Montes M, Arnes L. lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer? Expert Opin Ther Targets 2021;25:521-8. [PMID: 34077329 DOI: 10.1080/14728222.2021.1938541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Smolarz B, Zadrożna-Nowak A, Romanowicz H. The Role of lncRNA in the Development of Tumors, including Breast Cancer. Int J Mol Sci 2021;22:8427. [PMID: 34445129 DOI: 10.3390/ijms22168427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
136 Sharma A, Kansara S, Mahajan M, Yadav B, Garg M, Pandey AK. Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Biochim Biophys Acta Mol Basis Dis 2021;1867:166240. [PMID: 34363933 DOI: 10.1016/j.bbadis.2021.166240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
137 Lee EY, Song JM, Kim HJ, Park HR. Hypomethylation of lncRNA H19 as a potential prognostic biomarker for oral squamous cell carcinoma. Arch Oral Biol 2021;129:105214. [PMID: 34333230 DOI: 10.1016/j.archoralbio.2021.105214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
138 Policarpo R, Sierksma A, De Strooper B, d'Ydewalle C. From Junk to Function: LncRNAs in CNS Health and Disease. Front Mol Neurosci 2021;14:714768. [PMID: 34349622 DOI: 10.3389/fnmol.2021.714768] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
139 Lin S, Zhang W, Shi Z, Tan L, Zhu Y, Li H, Peng X. β-Catenin/LEF-1 transcription complex is responsible for the transcriptional activation of LINC01278. Cancer Cell Int 2021;21:380. [PMID: 34273985 DOI: 10.1186/s12935-021-02082-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
140 Monteiro LJ, Peñailillo R, Sánchez M, Acuña-Gallardo S, Mönckeberg M, Ong J, Choolani M, Illanes SE, Nardocci G. The Role of Long Non-Coding RNAs in Trophoblast Regulation in Preeclampsia and Intrauterine Growth Restriction. Genes (Basel) 2021;12:970. [PMID: 34201957 DOI: 10.3390/genes12070970] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
141 Di Fiore R, Suleiman S, Felix A, O'Toole SA, O'Leary JJ, Ward MP, Beirne J, Sabol M, Ozretić P, Yordanov A, Vasileva-Slaveva M, Kostov S, Nikolova M, Said-Huntingford I, Ayers D, Ellul B, Pentimalli F, Giordano A, Calleja-Agius J. An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma. Int J Mol Sci 2021;22:6506. [PMID: 34204445 DOI: 10.3390/ijms22126506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
142 Papaspyropoulos A, Lagopati N, Mourkioti I, Angelopoulou A, Kyriazis S, Liontos M, Gorgoulis V, Kotsinas A. Regulatory and Functional Involvement of Long Non-Coding RNAs in DNA Double-Strand Break Repair Mechanisms. Cells 2021;10:1506. [PMID: 34203749 DOI: 10.3390/cells10061506] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
143 Wang B, Deng Y, Jin J, Wu Y, Shen L. Long Noncoding RNA LIT3527 Knockdown induces Apoptosis and Autophagy through inhibiting mTOR pathway in Gastric Cancer Cells. J Cancer 2021;12:4901-11. [PMID: 34234860 DOI: 10.7150/jca.58185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
144 François-Moutal L, Miranda VG, Mollasalehi N, Gokhale V, Khanna M. In Silico Targeting of the Long Noncoding RNA MALAT1. ACS Med Chem Lett 2021;12:915-21. [PMID: 34141069 DOI: 10.1021/acsmedchemlett.1c00060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
145 Jin F, Li J, Zhang YB, Liu X, Cai M, Liu M, Li M, Ma C, Yue R, Zhu Y, Lai R, Wang Z, Ji X, Wei H, Dong J, Liu Z, Wang Y, Sun Y, Wang X. A functional motif of long noncoding RNA Nron against osteoporosis. Nat Commun 2021;12:3319. [PMID: 34083547 DOI: 10.1038/s41467-021-23642-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
146 Zhang M, Gao F, Yu X, Zhang Q, Sun Z, He Y, Guo W. LINC00261: a burgeoning long noncoding RNA related to cancer. Cancer Cell Int 2021;21:274. [PMID: 34022894 DOI: 10.1186/s12935-021-01988-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
147 Yu AT, Berasain C, Bhatia S, Rivera K, Liu B, Rigo F, Pappin DJ, Spector DL. PHAROH lncRNA regulates Myc translation in hepatocellular carcinoma via sequestering TIAR. Elife 2021;10:e68263. [PMID: 34002693 DOI: 10.7554/eLife.68263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
148 Kim SH, Lim KH, Yang S, Joo JY. Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets. J Hematol Oncol 2021;14:77. [PMID: 33980320 DOI: 10.1186/s13045-021-01088-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
149 Tassinari M, Richter SN, Gandellini P. Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome. Nucleic Acids Res 2021;49:3617-33. [PMID: 33721024 DOI: 10.1093/nar/gkab127] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
150 Li G, Kryczek I, Nam J, Li X, Li S, Li J, Wei S, Grove S, Vatan L, Zhou J, Du W, Lin H, Wang T, Subramanian C, Moon JJ, Cieslik M, Cohen M, Zou W. LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nat Cell Biol 2021;23:526-37. [PMID: 33958760 DOI: 10.1038/s41556-021-00672-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 18.5] [Reference Citation Analysis]
151 Takeiwa T, Ikeda K, Horie-Inoue K, Inoue S. Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer. Front Cell Dev Biol 2021;9:641963. [PMID: 33996797 DOI: 10.3389/fcell.2021.641963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Frank F, Kavousi N, Bountali A, Dammer EB, Mourtada-Maarabouni M, Ortlund EA. The lncRNA Growth Arrest Specific 5 Regulates Cell Survival via Distinct Structural Modules with Independent Functions. Cell Rep 2020;32:107933. [PMID: 32697996 DOI: 10.1016/j.celrep.2020.107933] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
153 Yadav VK, Kumar A, Tripathi PP, Gupta J. Long noncoding RNAs in intestinal homeostasis, regeneration, and cancer. J Cell Physiol 2021. [PMID: 33899236 DOI: 10.1002/jcp.30393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
154 Xu F, Wu H, Xiong J, Peng T. Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation. Front Mol Biosci 2021;8:645365. [PMID: 33968986 DOI: 10.3389/fmolb.2021.645365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
155 Zhao H, Li J, Yan X, Bian X. LncRNA MAFG-AS1 Suppresses the Maturation of miR-34a to Promote Glioblastoma Cell Proliferation. Cancer Manag Res 2021;13:3493-501. [PMID: 33911899 DOI: 10.2147/CMAR.S274615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
156 Ghafouri-Fard S, Gholipour M, Hussen BM, Taheri M. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Front Oncol 2021;11:649107. [PMID: 33968749 DOI: 10.3389/fonc.2021.649107] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
157 Su H, Xie J, Wen L, Wang S, Chen S, Li J, Qi C, Zhang Q, He X, Zheng L, Wang L. LncRNA Gas5 regulates Fn1 deposition via Creb5 in renal fibrosis. Epigenomics 2021;13:699-713. [PMID: 33876672 DOI: 10.2217/epi-2020-0449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
158 Coellar JD, Long J, Danesh FR. Long Noncoding RNAs and Their Therapeutic Promise in Diabetic Nephropathy. Nephron 2021;145:404-14. [PMID: 33853077 DOI: 10.1159/000515422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
159 Luo J, Zheng J, Hao W, Zeng H, Zhang Z, Shao G. lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer. Oncol Lett 2021;21:471. [PMID: 33907581 DOI: 10.3892/ol.2021.12732] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
160 Zhang T, Beeharry MK, Wang Z, Zhu Z, Li J, Li C. YY1-modulated long non-coding RNA SNHG12 promotes gastric cancer metastasis by activating the miR-218-5p/YWHAZ axis. Int J Biol Sci 2021;17:1629-43. [PMID: 33994849 DOI: 10.7150/ijbs.58921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
161 Ye S, Ni Y. lncRNA SNHG9 Promotes Cell Proliferation, Migration, and Invasion in Human Hepatocellular Carcinoma Cells by Increasing GSTP1 Methylation, as Revealed by CRISPR-dCas9. Front Mol Biosci 2021;8:649976. [PMID: 33898523 DOI: 10.3389/fmolb.2021.649976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
162 Liu J, Qu X. The roles of long non-coding RNAs in ocular diseases. Exp Eye Res 2021;207:108561. [PMID: 33812869 DOI: 10.1016/j.exer.2021.108561] [Reference Citation Analysis]
163 Jiang L, Xie X, Ding F, Mei J, Bi R. Silencing LINC00511 inhibits cell proliferation, migration, and epithelial-mesenchymal transition via the PTEN-AKT-FOXO1 signaling pathway in lung cancer. Biochem Cell Biol 2021;99:1-8. [PMID: 31415720 DOI: 10.1139/bcb-2018-0364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
164 Diermeier SD, Chang K, Frewen A, Taaffe P, Grans JC, Xiong H, Benz BA, Russo S, Nowak D, Hearn S, Yu A, Wilkinson JE, Rigo F, Spector DL. The long non-coding RNA MaTAR20 promotes mammary tumor growth by regulating angiogenesis pathways.. [DOI: 10.1101/2021.03.30.437774] [Reference Citation Analysis]
165 Xu Y, Qiu M, Shen M, Dong S, Ye G, Shi X, Sun M. The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism. Mol Ther 2021;29:2209-18. [PMID: 33775912 DOI: 10.1016/j.ymthe.2021.03.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
166 Jiang L, Cheng C, Ji W, Wang H, Du Q, Dong X, Shao J, Yu W. LINC01116 promotes the proliferation and invasion of glioma by regulating the microRNA‑744‑5p‑MDM2‑p53 axis. Mol Med Rep 2021;23:366. [PMID: 33760190 DOI: 10.3892/mmr.2021.12005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Prasad A, Prasad M. Host-virus interactions mediated by long non-coding RNAs. Virus Res 2021;298:198402. [PMID: 33771610 DOI: 10.1016/j.virusres.2021.198402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
168 Wong LS, Wong CM. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma. Int J Mol Sci 2021;22:3137. [PMID: 33808647 DOI: 10.3390/ijms22063137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
169 Maruyama R, Yokota T. Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers. Methods Mol Biol 2020;2176:49-56. [PMID: 32865781 DOI: 10.1007/978-1-0716-0771-8_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
170 Zhang C, Liu H, Xu P, Tan Y, Xu Y, Wang L, Liu B, Chen Q, Tian D. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis. BMC Cancer 2021;21:251. [PMID: 33750353 DOI: 10.1186/s12885-021-07972-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, Hahne JC. MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Target Oncol. 2020;15:261-278. [PMID: 32451752 DOI: 10.1007/s11523-020-00717-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 32.5] [Reference Citation Analysis]
172 Merdrignac A, Papoutsoglou P, Coulouarn C. Long Noncoding RNAs in Cholangiocarcinoma. Hepatology 2021;73:1213-26. [PMID: 32865244 DOI: 10.1002/hep.31534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
173 Liu H, Zhang M, Shi M, Zhang T, Zhang Z, Cui Q, Yang S, Li Z. A Survival-Related Competitive Endogenous RNA Network of Prognostic lncRNAs, miRNAs, and mRNAs in Wilms Tumor. Front Oncol 2021;11:608433. [PMID: 33718161 DOI: 10.3389/fonc.2021.608433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
174 Li Z, Lin W, Zheng J, Hong W, Zou J, Zhang T, Chen Y, Lu H. Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer. Biosci Rep 2021;41:BSR20204086. [PMID: 33554245 DOI: 10.1042/BSR20204086] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
175 Chang KC, Spector DL. MaTAR25: a long non-coding RNA involved in breast cancer progression. Mol Cell Oncol 2021;8:1882286. [PMID: 33860086 DOI: 10.1080/23723556.2021.1882286] [Reference Citation Analysis]
176 Lingua MF, Carrà G, Maffeo B, Morotti A. Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe. Pharmaceuticals (Basel) 2021;14:168. [PMID: 33669945 DOI: 10.3390/ph14020168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
177 Hegre SA, Samdal H, Klima A, Stovner EB, Nørsett KG, Liabakk NB, Olsen LC, Chawla K, Aas PA, Sætrom P. Joint changes in RNA, RNA polymerase II, and promoter activity through the cell cycle identify non-coding RNAs involved in proliferation.. [DOI: 10.1101/2021.02.12.430890] [Reference Citation Analysis]
178 Boliar S, Russell DG. Lnc(ing)RNAs to the "shock and kill" strategy for HIV-1 cure. Mol Ther Nucleic Acids 2021;23:1272-80. [PMID: 33717648 DOI: 10.1016/j.omtn.2021.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
179 López-Noriega L, Rutter GA. Long Non-Coding RNAs as Key Modulators of Pancreatic β-Cell Mass and Function. Front Endocrinol (Lausanne) 2020;11:610213. [PMID: 33628198 DOI: 10.3389/fendo.2020.610213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
180 Ming H, Li B, Zhou L, Goel A, Huang C. Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications. Biochim Biophys Acta Rev Cancer 2021;1875:188519. [PMID: 33548345 DOI: 10.1016/j.bbcan.2021.188519] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
181 Chen Y, Li Z, Chen X, Zhang S. Long non-coding RNAs: From disease code to drug role. Acta Pharm Sin B 2021;11:340-54. [PMID: 33643816 DOI: 10.1016/j.apsb.2020.10.001] [Cited by in Crossref: 97] [Cited by in F6Publishing: 112] [Article Influence: 48.5] [Reference Citation Analysis]
182 Guo YP, Wang ZF, Li N, Lei QQ, Cheng Q, Shi LG, Zhou SL, Wang XH, Sun Y, Kong LF. Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126/EGFL7 axis. Am J Physiol Cell Physiol 2021;320:C880-91. [PMID: 33502949 DOI: 10.1152/ajpcell.00459.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
183 Bamunuarachchi G, Pushparaj S, Liu L. Interplay between host non-coding RNAs and influenza viruses. RNA Biol 2021;18:767-84. [PMID: 33404285 DOI: 10.1080/15476286.2021.1872170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
184 Xing J, Liu H, Jiang W, Wang L. LncRNA-Encoded Peptide: Functions and Predicting Methods. Front Oncol 2020;10:622294. [PMID: 33520729 DOI: 10.3389/fonc.2020.622294] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
185 Chen HW, Zhang XX, Peng ZD, Xing ZM, Zhang YW, Li YL. The circular RNA circSlc7a11 promotes bone cancer pain pathogenesis in rats by modulating LLC-WRC 256 cell proliferation and apoptosis. Mol Cell Biochem 2021;476:1751-63. [PMID: 33433832 DOI: 10.1007/s11010-020-04020-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
186 Luo D, Liu F, Zhang J, Shao Q, Tao W, Xiao R, Dai W, Qian K. Functional crosstalk between Long non-coding RNAs and the NLRP3 inflammasome in the regulation of diseases. Mol Immunol 2021;131:191-200. [PMID: 33446392 DOI: 10.1016/j.molimm.2020.12.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
187 Bhardwaj V, Tan YQ, Wu MM, Ma L, Zhu T, Lobie PE, Pandey V. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives. Cancer Lett 2021;502:97-107. [PMID: 33429007 DOI: 10.1016/j.canlet.2020.12.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
188 Yu H, Li SB. Role of LINC00152 in non-small cell lung cancer. J Zhejiang Univ Sci B 2020;21:179-91. [PMID: 32133796 DOI: 10.1631/jzus.B1900312] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
189 Tong H, Li T, Gao S, Yin H, Cao H, He W. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer. Biosci Rep 2021;41:BSR20203944. [PMID: 33289830 DOI: 10.1042/BSR20203944] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
190 Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 2021;20:629-51. [PMID: 34145432 DOI: 10.1038/s41573-021-00219-z] [Cited by in Crossref: 348] [Cited by in F6Publishing: 339] [Article Influence: 174.0] [Reference Citation Analysis]
191 Ghosh S, Samanta A, Prasad P, Sinha D. Therapeutic Implications of Long Non-coding RNA in the Regulation of Lung Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2021. [DOI: 10.1007/978-981-16-1247-3_70-1] [Reference Citation Analysis]
192 Nandwani A, Rathore S, Datta M. LncRNAs in cancer: Regulatory and therapeutic implications. Cancer Lett 2021;501:162-71. [PMID: 33359709 DOI: 10.1016/j.canlet.2020.11.048] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 11.0] [Reference Citation Analysis]
193 Wu M, Zhang X, Han X, Pandey V, Lobie PE, Zhu T. The potential of long noncoding RNAs for precision medicine in human cancer. Cancer Lett 2021;501:12-9. [PMID: 33359450 DOI: 10.1016/j.canlet.2020.11.040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
194 Omote N, Sauler M. Non-coding RNAs as Regulators of Cellular Senescence in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease. Front Med (Lausanne) 2020;7:603047. [PMID: 33425948 DOI: 10.3389/fmed.2020.603047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
195 Chang KC, Diermeier SD, Yu AT, Brine LD, Russo S, Bhatia S, Alsudani H, Kostroff K, Bhuiya T, Brogi E, Pappin DJ, Bennett CF, Rigo F, Spector DL. MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression. Nat Commun 2020;11:6438. [PMID: 33353933 DOI: 10.1038/s41467-020-20207-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
196 Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, Liu H, Fan T. Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers. Front Oncol 2020;10:598817. [PMID: 33392092 DOI: 10.3389/fonc.2020.598817] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 16.3] [Reference Citation Analysis]
197 Pang Z, Chen X, Wang Y, Wang Y, Yan T, Wan J, Wang K, Du J. Long non-coding RNA C5orf64 is a potential indicator for tumor microenvironment and mutation pattern remodeling in lung adenocarcinoma. Genomics 2021;113:291-304. [PMID: 33309768 DOI: 10.1016/j.ygeno.2020.12.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
198 Amaral MS, Maciel LF, Silveira GO, Olberg GGO, Leite JVP, Imamura LK, Pereira ASA, Miyasato PA, Nakano E, Verjovski-Almeida S. Long non-coding RNA levels can be modulated by 5-azacytidine in Schistosoma mansoni. Sci Rep 2020;10:21565. [PMID: 33299037 DOI: 10.1038/s41598-020-78669-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
199 Lucere KM, O'Malley MMR, Diermeier SD. Functional Screening Techniques to Identify Long Non-Coding RNAs as Therapeutic Targets in Cancer. Cancers (Basel) 2020;12:E3695. [PMID: 33317042 DOI: 10.3390/cancers12123695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
200 Zhu W, Gao W, Deng Y, Yu X, Zhu H. Identification and Development of Long Non-coding RNA Associated Regulatory Network in Pancreatic Adenocarcinoma. Onco Targets Ther 2020;13:12083-96. [PMID: 33262608 DOI: 10.2147/OTT.S265036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
201 Jiang M, Cheng Y, Wang D, Lu Y, Gu S, Wang C, Huang Y, Li Y. Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer. EBioMedicine 2021;63:103150. [PMID: 33279858 DOI: 10.1016/j.ebiom.2020.103150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
202 Li D, Fan X, Li Y, Yang J, Lin H. The paradoxical functions of long noncoding RNAs in hepatocellular carcinoma: Implications in therapeutic opportunities and precision medicine. Genes & Diseases 2020. [DOI: 10.1016/j.gendis.2020.11.014] [Reference Citation Analysis]
203 Wolska M, Jarosz-Popek J, Junger E, Wicik Z, Porshoor T, Sharif L, Czajka P, Postula M, Mirowska-Guzel D, Czlonkowska A, Eyileten C. Long Non-coding RNAs as Promising Therapeutic Approach in Ischemic Stroke: a Comprehensive Review. Mol Neurobiol 2021;58:1664-82. [PMID: 33236327 DOI: 10.1007/s12035-020-02206-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
204 Hafeez N, Chan SY. A New "TYK" Tok Era for the Study of Long Noncoding RNAs in Pulmonary Hypertension. Am J Respir Crit Care Med 2020;202:1339-41. [PMID: 32726562 DOI: 10.1164/rccm.202007-2632ED] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
205 Long B, Yang X, Xu X, Li X, Xu X, Zhang X, Zhang S. Long noncoding RNA ASB16-AS1 inhibits adrenocortical carcinoma cell growth by promoting ubiquitination of RNA-binding protein HuR. Cell Death Dis 2020;11:995. [PMID: 33219221 DOI: 10.1038/s41419-020-03205-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
206 Fang Z, Xu J, Zhang B, Wang W, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives. J Hematol Oncol 2020;13:154. [PMID: 33213510 DOI: 10.1186/s13045-020-00988-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
207 Abdi E, Latifi-navid S, Abdi F, Taherian-esfahani Z. Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers. Expert Review of Molecular Diagnostics 2020;20:1121-38. [DOI: 10.1080/14737159.2020.1842199] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
208 Shirahama S, Onoguchi-Mizutani R, Kawata K, Taniue K, Miki A, Kato A, Kawaguchi Y, Tanaka R, Kaburaki T, Kawashima H, Urade Y, Aihara M, Akimitsu N. Long noncoding RNA U90926 is crucial for herpes simplex virus type 1 proliferation in murine retinal photoreceptor cells. Sci Rep 2020;10:19406. [PMID: 33173149 DOI: 10.1038/s41598-020-76450-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
209 Zapparoli E, Briata P, Rossi M, Brondolo L, Bucci G, Gherzi R. Comprehensive multi-omics analysis uncovers a group of TGF-β-regulated genes among lncRNA EPR direct transcriptional targets. Nucleic Acids Res 2020;48:9053-66. [PMID: 32756918 DOI: 10.1093/nar/gkaa628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
210 Zhang Q, Chen Z. lncRNA UASR1 sponges miR-107 in colorectal cancer to upregulate oncogenic CDK8 and promote cell proliferation. Oncol Lett 2020;20:305. [PMID: 33093914 DOI: 10.3892/ol.2020.12168] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
211 Zhou D, Wu Y, Wang S, Li J, Luan J. Harnessing noncoding RNA-based macrophage polarization: Emerging therapeutic opportunities for fibrosis. Immun Inflamm Dis 2020;8:793-806. [PMID: 33080104 DOI: 10.1002/iid3.341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
212 Olivero CE, Dimitrova N. Identification and characterization of functional long noncoding RNAs in cancer. FASEB J 2020;34:15630-46. [PMID: 33058262 DOI: 10.1096/fj.202001951R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
213 Arman K, Möröy T. Crosstalk Between MYC and lncRNAs in Hematological Malignancies. Front Oncol 2020;10:579940. [PMID: 33134177 DOI: 10.3389/fonc.2020.579940] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
214 Zhao W, Jin Y, Wu P, Yang J, Chen Y, Yang Q, Huo X, Li J, De W, Chen J, Yang F. LINC00355 induces gastric cancer proliferation and invasion through promoting ubiquitination of P53. Cell Death Discov 2020;6:99. [PMID: 33083020 DOI: 10.1038/s41420-020-00332-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
215 Liang Q, Guan G, Li X, Wei C, Wu J, Cheng P, Wu A, Cheng W. Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma. J Transl Med 2020;18:378. [PMID: 33028341 DOI: 10.1186/s12967-020-02552-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
216 Chen M, Huang B, Zhu L, Chen K, Liu M, Zhong C. Structural and Functional Overview of TEAD4 in Cancer Biology. Onco Targets Ther 2020;13:9865-74. [PMID: 33116572 DOI: 10.2147/OTT.S266649] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
217 Neve B, Jonckheere N, Vincent A, Van Seuningen I. Long non-coding RNAs: the tentacles of chromatin remodeler complexes. Cell Mol Life Sci 2021;78:1139-61. [DOI: 10.1007/s00018-020-03646-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
218 Yang Z, Li G, Ding C, Sun W, Zhang J. Long non-coding RNA HULC exerts oncogenic activity on papillary thyroid cancer in vitro and in vivo. Artif Cells Nanomed Biotechnol 2020;48:326-35. [PMID: 31878795 DOI: 10.1080/21691401.2019.1703730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
219 Hu C, Fang K, Zhang X, Guo Z, Li L. Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer. Pathol Res Pract 2020;216:153216. [PMID: 32961484 DOI: 10.1016/j.prp.2020.153216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
220 Zhao S, Zhang X, Chen S, Zhang S. Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark. J Exp Clin Cancer Res 2020;39:187. [PMID: 32928281 DOI: 10.1186/s13046-020-01700-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
221 Song XZ, Ren XN, Xu XJ, Ruan XX, Wang YL, Yao TT. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. Technol Cancer Res Treat 2020;19:1533033820957023. [PMID: 32910747 DOI: 10.1177/1533033820957023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
222 Uchida S, Kauppinen S. Long Non-Coding RNAs in Liver Cancer and Nonalcoholic Steatohepatitis. Noncoding RNA 2020;6:E34. [PMID: 32872482 DOI: 10.3390/ncrna6030034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
223 Pandya G, Kirtonia A, Sethi G, Pandey AK, Garg M. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. Biochim Biophys Acta Rev Cancer 2020;1874:188423. [PMID: 32871244 DOI: 10.1016/j.bbcan.2020.188423] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 20.7] [Reference Citation Analysis]
224 Fathi Dizaji B. Strategies to target long non-coding RNAs in cancer treatment: progress and challenges. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-00074-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
225 Elsayed AM, Amero P, Salama SA, Abdelaziz AH, Lopez-Berestein G, Rodriguez-Aguayo C. Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer. Cancers (Basel) 2020;12:E2406. [PMID: 32854207 DOI: 10.3390/cancers12092406] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
226 Fang Z, Wang Y, Wang Z, Xu M, Ren S, Yang D, Hong M, Xie W. ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway. Cancer Res 2020;80:4399-413. [PMID: 32826278 DOI: 10.1158/0008-5472.CAN-20-1031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
227 Ji Y, Xue Y. Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma. Onco Targets Ther 2020;13:8395-411. [PMID: 32904613 DOI: 10.2147/OTT.S257200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
228 Poli G, Fabi C, Bellet MM, Costantini C, Nunziangeli L, Romani L, Brancorsini S. Epigenetic Mechanisms of Inflammasome Regulation. Int J Mol Sci 2020;21:E5758. [PMID: 32796686 DOI: 10.3390/ijms21165758] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
229 Collins L, Binder P, Chen H, Wang X. Regulation of Long Non-coding RNAs and MicroRNAs in Heart Disease: Insight Into Mechanisms and Therapeutic Approaches. Front Physiol 2020;11:798. [PMID: 32754048 DOI: 10.3389/fphys.2020.00798] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
230 French JD, Edwards SL. The Role of Noncoding Variants in Heritable Disease. Trends Genet 2020;36:880-91. [PMID: 32741549 DOI: 10.1016/j.tig.2020.07.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
231 Han H, Li H, Zhou J. Long non-coding RNA MIR503HG inhibits the proliferation, migration and invasion of colon cancer cells via miR-107/Par4 axis. Exp Cell Res 2020;395:112205. [PMID: 32738347 DOI: 10.1016/j.yexcr.2020.112205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
232 Squillaro T, Peluso G, Galderisi U, Di Bernardo G. Long non-coding RNAs in regulation of adipogenesis and adipose tissue function. Elife 2020;9:e59053. [PMID: 32730204 DOI: 10.7554/eLife.59053] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
233 Wu J, Guo X, Xu D, Zhang H. LINC00662 sponges miR-107 accelerating the invasiveness and proliferation of glioma cells. J Cancer 2020;11:5700-12. [PMID: 32913464 DOI: 10.7150/jca.46381] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
234 Cui K, Zhu G. LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation. J Ovarian Res 2020;13:84. [PMID: 32711584 DOI: 10.1186/s13048-020-00689-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
235 Du T, Shi Y, Xu S, Wan X, Sun H, Liu B. Long Non-Coding RNAs in Drug Resistance of Breast Cancer. Onco Targets Ther 2020;13:7075-87. [PMID: 32764993 DOI: 10.2147/OTT.S255226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
236 Nozawa RS, Yamamoto T, Takahashi M, Tachiwana H, Maruyama R, Hirota T, Saitoh N. Nuclear microenvironment in cancer: Control through liquid-liquid phase separation. Cancer Sci 2020;111:3155-63. [PMID: 32594560 DOI: 10.1111/cas.14551] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
237 Liu J, Wang Y, Chu Y, Xu R, Zhang D, Wang X. Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma. Front Cell Dev Biol 2020;8:649. [PMID: 32850794 DOI: 10.3389/fcell.2020.00649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
238 Rolland AD, Evrard B, Darde TA, Le Béguec C, Le Bras Y, Bensalah K, Lavoué S, Jost B, Primig M, Dejucq-Rainsford N, Chalmel F, Jégou B. RNA profiling of human testicular cells identifies syntenic lncRNAs associated with spermatogenesis. Hum Reprod 2019;34:1278-90. [PMID: 31247106 DOI: 10.1093/humrep/dez063] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
239 Tan H, Zhang S, Zhang J, Zhu L, Chen Y, Yang H, Chen Y, An Y, Liu B. Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications. Theranostics 2020;10:8880-902. [PMID: 32754285 DOI: 10.7150/thno.47548] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
240 Lian Y, Yan C, Lian Y, Yang R, Chen Q, Ma D, Lian W, Liu J, Luo C, Ren J, Xu H. Long intergenic non-protein-coding RNA 01446 facilitates the proliferation and metastasis of gastric cancer cells through interacting with the histone lysine-specific demethylase LSD1. Cell Death Dis 2020;11:522. [PMID: 32651355 DOI: 10.1038/s41419-020-2729-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
241 Ginn L, Shi L, Montagna M, Garofalo M. LncRNAs in Non-Small-Cell Lung Cancer. Noncoding RNA 2020;6:E25. [PMID: 32629922 DOI: 10.3390/ncrna6030025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
242 Gandhi M, Groß M, Holler JM, Coggins SA, Patil N, Leupold JH, Munschauer M, Schenone M, Hartigan CR, Allgayer H, Kim B, Diederichs S. The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer. Nat Commun 2020;11:3214. [PMID: 32587247 DOI: 10.1038/s41467-020-17007-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
243 Grillone K, Riillo C, Scionti F, Rocca R, Tradigo G, Guzzi PH, Alcaro S, Di Martino MT, Tagliaferri P, Tassone P. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter". J Exp Clin Cancer Res 2020;39:117. [PMID: 32563270 DOI: 10.1186/s13046-020-01622-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 76] [Article Influence: 22.7] [Reference Citation Analysis]
244 Ali HS, Boshra MS, El Meteini MS, Shafei AE, Matboli M. lncRNA- RP11-156p1.3, novel diagnostic and therapeutic targeting via CRISPR/Cas9 editing in hepatocellular carcinoma. Genomics 2020;112:3306-14. [PMID: 32544548 DOI: 10.1016/j.ygeno.2020.06.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
245 Liu L, Li Y, Zhang R, Li C, Xiong J, Wei Y. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis. BMC Pulm Med 2020;20:163. [PMID: 32513149 DOI: 10.1186/s12890-020-1174-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
246 Jain AK. Emerging roles of long non-coding RNAs in the p53 network. RNA Biol 2020;17:1648-56. [PMID: 32432959 DOI: 10.1080/15476286.2020.1770981] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
247 Lv P, Ye T, Yang X, Liu H, Ye Z. High expression of long noncoding RNA LUCAT1 correlates with a poor clinical outcome in solid tumors: A systematic review and meta-analysis. Pathol Res Pract 2020;216:153047. [PMID: 32825932 DOI: 10.1016/j.prp.2020.153047] [Reference Citation Analysis]
248 Lin S, Zhen Y, Guan Y, Yi H. Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer. Cancer Manag Res 2020;12:4181-91. [PMID: 32581590 DOI: 10.2147/CMAR.S241519] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
249 Zhou R, Joshi P, Katsushima K, Liang W, Liu W, Goldenberg NA, Dover G, Perera RJ. The Emerging Field of Noncoding RNAs and Their Importance in Pediatric Diseases. J Pediatr 2020;221S:S11-9. [PMID: 32482229 DOI: 10.1016/j.jpeds.2020.02.078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
250 Arun G, Aggarwal D, Spector DL. MALAT1 Long Non-Coding RNA: Functional Implications. Noncoding RNA 2020;6:E22. [PMID: 32503170 DOI: 10.3390/ncrna6020022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 16.7] [Reference Citation Analysis]
251 Takeiwa T, Ikeda K, Mitobe Y, Horie-Inoue K, Inoue S. Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer. Cancers (Basel) 2020;12:E1424. [PMID: 32486413 DOI: 10.3390/cancers12061424] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
252 Ashrafizadeh M, Zarrabi A, Samarghandian S, Najafi M. PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer? Eur J Pharmacol 2020;881:173226. [PMID: 32485246 DOI: 10.1016/j.ejphar.2020.173226] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
253 Hu Q, Egranov SD, Lin C, Yang L. Long noncoding RNA loss in immune suppression in cancer. Pharmacol Ther 2020;213:107591. [PMID: 32473960 DOI: 10.1016/j.pharmthera.2020.107591] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
254 Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ, Cheng XD. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer. 2020;19:96. [PMID: 32460771 DOI: 10.1186/s12943-020-01219-0] [Cited by in Crossref: 110] [Cited by in F6Publishing: 119] [Article Influence: 36.7] [Reference Citation Analysis]
255 Slack FJ, Chinnaiyan AM. The Role of Non-coding RNAs in Oncology. Cell 2019;179:1033-55. [PMID: 31730848 DOI: 10.1016/j.cell.2019.10.017] [Cited by in Crossref: 521] [Cited by in F6Publishing: 563] [Article Influence: 173.7] [Reference Citation Analysis]
256 Hu D, Zhang B, Yu M, Shi W, Zhang L. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network. Mol Med Rep 2020;22:620-32. [PMID: 32468035 DOI: 10.3892/mmr.2020.11171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
257 Esmaeili M, Keshani M, Vakilian M, Esmaeili M, Peymani M, Seyed Forootan F, Chau TL, Göktuna SI, Zaker SR, Nasr Esfahani MH, Ghaedi K. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways. Gene 2020;753:144796. [PMID: 32450203 DOI: 10.1016/j.gene.2020.144796] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
258 Cui Z, Pu T, Zhang Y, Wang J, Zhao Y. Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p. Open Biol 2020;10:190286. [PMID: 32397872 DOI: 10.1098/rsob.190286] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
259 Msaouel P, Malouf GG, Su X, Yao H, Tripathi DN, Soeung M, Gao J, Rao P, Coarfa C, Creighton CJ, Bertocchio JP, Kunnimalaiyaan S, Multani AS, Blando J, He R, Shapiro DD, Perelli L, Srinivasan S, Carbone F, Pilié PG, Karki M, Seervai RNH, Vokshi BH, Lopez-Terrada D, Cheng EH, Tang X, Lu W, Wistuba II, Thompson TC, Davidson I, Giuliani V, Schlacher K, Carugo A, Heffernan TP, Sharma P, Karam JA, Wood CG, Walker CL, Genovese G, Tannir NM. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. Cancer Cell 2020;37:720-734.e13. [PMID: 32359397 DOI: 10.1016/j.ccell.2020.04.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
260 Zhang X, Ong'achwa Machuki J, Pan W, Cai W, Xi Z, Shen F, Zhang L, Yang Y, Gao F, Guan M. Carbon Nitride Hollow Theranostic Nanoregulators Executing Laser-Activatable Water Splitting for Enhanced Ultrasound/Fluorescence Imaging and Cooperative Phototherapy. ACS Nano 2020;14:4045-60. [PMID: 32255341 DOI: 10.1021/acsnano.9b08737] [Cited by in Crossref: 86] [Cited by in F6Publishing: 96] [Article Influence: 28.7] [Reference Citation Analysis]
261 Lu Y, Chan YT, Tan HY, Li S, Wang N, Feng Y. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy. Mol Cancer 2020;19:79. [PMID: 32340605 DOI: 10.1186/s12943-020-01197-3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 103] [Article Influence: 30.7] [Reference Citation Analysis]
262 Zhang Q, Jin X, Shi W, Chen X, Pang W, Yu X, Yang L. A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis. Cancer Cell Int 2020;20:137. [PMID: 32355466 DOI: 10.1186/s12935-020-01221-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
263 Lin YH. Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer. Int J Mol Sci 2020;21:E2947. [PMID: 32331347 DOI: 10.3390/ijms21082947] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
264 Tiwari PK. Epigenetic Biomarkers in Gallbladder Cancer. Trends Cancer 2020;6:540-3. [PMID: 32291238 DOI: 10.1016/j.trecan.2020.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
265 DeOcesano-Pereira C, Machado RAC, Chudzinski-Tavassi AM, Sogayar MC. Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma. Int J Mol Sci 2020;21:E2611. [PMID: 32283739 DOI: 10.3390/ijms21072611] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
266 Jin KT, Yao JY, Fang XL, Di H, Ma YY. Roles of lncRNAs in cancer: Focusing on angiogenesis. Life Sci 2020;252:117647. [PMID: 32275935 DOI: 10.1016/j.lfs.2020.117647] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 11.7] [Reference Citation Analysis]
267 Zimta AA, Tigu AB, Braicu C, Stefan C, Ionescu C, Berindan-Neagoe I. An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes. Front Oncol 2020;10:389. [PMID: 32318335 DOI: 10.3389/fonc.2020.00389] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 18.3] [Reference Citation Analysis]
268 Tang F, Xu Y, Wang H, Bian E, Zhao B. LncRNA-ATB in cancers: what do we know so far? Mol Biol Rep 2020;47:4077-86. [PMID: 32248383 DOI: 10.1007/s11033-020-05415-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
269 Bayoumi A, Grønbæk H, George J, Eslam M. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease. Trends Genet 2020;36:429-41. [PMID: 32396836 DOI: 10.1016/j.tig.2020.03.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
270 Zheng X, Zhang J, Fang T, Wang X, Wang S, Ma Z, Xu Y, Han C, Sun M, Xu L, Wang J, Yin R. The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway. Oncogenesis 2020;9:34. [PMID: 32165621 DOI: 10.1038/s41389-020-0217-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
271 Chong C, Müller M, Pak H, Harnett D, Huber F, Grun D, Leleu M, Auger A, Arnaud M, Stevenson BJ, Michaux J, Bilic I, Hirsekorn A, Calviello L, Simó-Riudalbas L, Planet E, Lubiński J, Bryśkiewicz M, Wiznerowicz M, Xenarios I, Zhang L, Trono D, Harari A, Ohler U, Coukos G, Bassani-Sternberg M. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat Commun 2020;11:1293. [PMID: 32157095 DOI: 10.1038/s41467-020-14968-9] [Cited by in Crossref: 95] [Cited by in F6Publishing: 111] [Article Influence: 31.7] [Reference Citation Analysis]
272 Yang Q, Wang J, Zhong P, Mou T, Hua H, Liu P, Xie F. The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis. Cancer Cell Int 2020;20:72. [PMID: 32165862 DOI: 10.1186/s12935-020-1148-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
273 Ghaffari Sharaf M, Damji KF, Unsworth LD. Recent advances in risk factors associated with ocular exfoliation syndrome. Acta Ophthalmol 2020;98:113-20. [PMID: 31736276 DOI: 10.1111/aos.14298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
274 Geng L, Xu X, Zhang H, Chen C, Hou Y, Yao G, Wang S, Wang D, Feng X, Sun L, Liang J. Comprehensive expression profile of long non-coding RNAs in Peripheral blood mononuclear cells from patients with neuropsychiatric systemic lupus erythematosus. Ann Transl Med 2020;8:349. [PMID: 32355793 DOI: 10.21037/atm.2020.03.25] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
275 An JJ, Li SY, Guan X, Xu XN, Jiang XJ. Clinical significance of expression of MEG8 and TGM2 genes in gastric cancer. Shijie Huaren Xiaohua Zazhi 2020; 28(4): 122-128 [DOI: 10.11569/wcjd.v28.i4.122] [Reference Citation Analysis]
276 Wang Y, Bao Y, Zhang S, Wang Z. Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets. Sci China Life Sci 2020;63:469-84. [PMID: 32086672 DOI: 10.1007/s11427-019-1605-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
277 Chang K, Diermeier SD, Yu AT, Brine LD, Russo S, Bhatia S, Alsudani H, Kostroff K, Bhuiya T, Brogi E, Bennett CF, Rigo F, Spector DL. MaTAR25LncRNA Regulates theTensin1Gene to Impact Breast Cancer Progression.. [DOI: 10.1101/2020.02.03.931881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
278 Martínez-Barriocanal Á, Arango D, Dopeso H. PVT1 Long Non-coding RNA in Gastrointestinal Cancer. Front Oncol 2020;10:38. [PMID: 32083000 DOI: 10.3389/fonc.2020.00038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
279 Hadjicharalambous MR, Lindsay MA. Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs. Int J Mol Sci 2020;21:E524. [PMID: 31947693 DOI: 10.3390/ijms21020524] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
280 Lu X, Qiao L, Liu Y. Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1. J Cell Biochem 2020;121:4064-73. [PMID: 31930565 DOI: 10.1002/jcb.29579] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
281 He W, Zhang Y, Xia S. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. Thorac Cancer 2020;11:549-60. [PMID: 31923353 DOI: 10.1111/1759-7714.13280] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
282 Zhang Y, Huang B, Chen Z, Yang S. Knockdown of LINC00473 Enhances Radiosensitivity in Hepatocellular Carcinoma via Regulating the miR-345-5p/FOXP1 Axis. Onco Targets Ther. 2020;13:173-183. [PMID: 32021265 DOI: 10.2147/ott.s240113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
283 Feng L, Li H, Li F, Bei S, Zhang X. LncRNA KCNQ1OT1 regulates microRNA-9-LMX1A expression and inhibits gastric cancer cell progression. Aging (Albany NY) 2020;12:707-17. [PMID: 31915311 DOI: 10.18632/aging.102651] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
284 Aprile M, Calin G, Cimmino A, Costa V. Tumorigenesis-Related Long Noncoding RNAs and Their Targeting as Therapeutic Approach in Cancer. RNA Technologies 2020. [DOI: 10.1007/978-3-030-44743-4_11] [Reference Citation Analysis]
285 Ulu GT, Kiraz Y, Baran Y. Personalized biomedicine in cancer: from traditional therapy to sustainable healthcare. Biodiversity and Biomedicine 2020. [DOI: 10.1016/b978-0-12-819541-3.00022-0] [Reference Citation Analysis]
286 Cieśla M. RNA in cancer. Rna-Based Regulation in Human Health and Disease 2020. [DOI: 10.1016/b978-0-12-817193-6.00011-x] [Reference Citation Analysis]
287 Souckova K, Catela Ivkovic T, Slaby O. Non-coding RNA therapy in cancer. Precision Medicine for Investigators, Practitioners and Providers 2020. [DOI: 10.1016/b978-0-12-819178-1.00020-4] [Reference Citation Analysis]
288 Xu Y, Wang H, Li F, Heindl LM, He X, Yu J, Yang J, Ge S, Ruan J, Jia R, Fan X. Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2. Front Cell Dev Biol 2019;7:350. [PMID: 31921860 DOI: 10.3389/fcell.2019.00350] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
289 Sun R, Wang R, Chang S, Li K, Sun R, Wang M, Li Z. Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review. Front Pharmacol 2019;10:1457. [PMID: 31920650 DOI: 10.3389/fphar.2019.01457] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
290 Guo S, Jian L, Tao K, Chen C, Yu H, Liu S. Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer. Front Oncol 2019;9:1325. [PMID: 31921620 DOI: 10.3389/fonc.2019.01325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
291 Zhang X, Li J, Li F, Zhao Z, Feng L. LINC00682 inhibits gastric cancer cell progression via targeting microRNA-9-LMX1A signaling axis. Aging (Albany NY) 2019;11:11358-68. [PMID: 31822638 DOI: 10.18632/aging.102533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
292 Malik A, Srinivasan S, Batra J. A New Era of Prostate Cancer Precision Medicine. Front Oncol 2019;9:1263. [PMID: 31850193 DOI: 10.3389/fonc.2019.01263] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
293 Jin SJ, Jin MZ, Xia BR, Jin WL. Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers. Front Oncol 2019;9:1225. [PMID: 31799189 DOI: 10.3389/fonc.2019.01225] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 10.5] [Reference Citation Analysis]
294 Boloix A, Masanas M, Jiménez C, Antonelli R, Soriano A, Roma J, Sánchez de Toledo J, Gallego S, Segura MF. Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer. Front Oncol 2019;9:1173. [PMID: 31781490 DOI: 10.3389/fonc.2019.01173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
295 Qiao K, Ning S, Wan L, Wu H, Wang Q, Zhang X, Xu S, Pang D. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway. J Exp Clin Cancer Res 2019;38:418. [PMID: 31623640 DOI: 10.1186/s13046-019-1421-7] [Cited by in Crossref: 76] [Cited by in F6Publishing: 84] [Article Influence: 19.0] [Reference Citation Analysis]
296 Lorenzi L, Chiu H, Cobos FA, Gross S, Volders P, Cannoodt R, Nuytens J, Vanderheyden K, Anckaert J, Lefever S, Goovaerts T, Hansen TB, Kuersten S, Nijs N, Taghon T, Vermaelen K, Bracke KR, Saeys Y, De Meyer T, Deshpande N, Anande G, Chen T, Wilkins MR, Unnikrishnan A, De Preter K, Kjems J, Koster J, Schroth GP, Vandesompele J, Sumazin P, Mestdagh P. The RNA Atlas, a single nucleotide resolution map of the human transcriptome.. [DOI: 10.1101/807529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
297 Hu J, Xu L, Shou T, Chen Q. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy. Transl Lung Cancer Res 2019;8:614-35. [PMID: 31737498 DOI: 10.21037/tlcr.2019.09.13] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
298 Cui P, Su J, Li Q, Xu G, Zhu N. LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells. Onco Targets Ther 2019;12:7911-21. [PMID: 31576148 DOI: 10.2147/OTT.S209563] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
299 Fang F, Zhang K, Chen Z, Wu B. Noncoding RNAs: new insights into the odontogenic differentiation of dental tissue-derived mesenchymal stem cells. Stem Cell Res Ther. 2019;10:297. [PMID: 31547871 DOI: 10.1186/s13287-019-1411-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
300 Zhao L, Hu K, Cao J, Wang P, Li J, Zeng K, He X, Tu PF, Tong T, Han L. lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescence. Aging (Albany NY) 2019;11:7098-122. [PMID: 31503007 DOI: 10.18632/aging.102240] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
301 Yuan LT, Chang JH, Lee HL, Yang YC, Su SC, Lin CL, Yang SF, Chien MH. Genetic Variants of lncRNA MALAT1 Exert Diverse Impacts on the Risk and Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma. J Clin Med 2019;8:E1406. [PMID: 31500187 DOI: 10.3390/jcm8091406] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
302 Chong C, Müller M, Pak H, Harnett D, Huber F, Grun D, Leleu M, Auger A, Arnaud M, Stevenson BJ, Michaux J, Bilic I, Hirsekorn A, Calviello L, Simó-riudalbas L, Planet E, Lubiński J, Bryśkiewicz M, Wiznerowicz M, Xenarios I, Zhang L, Trono D, Harari A, Ohler U, Coukos G, Bassani-sternberg M. Integrated Proteogenomic Deep Sequencing and Analytics Accurately Identify Non-Canonical Peptides in Tumor Immunopeptidomes.. [DOI: 10.1101/758680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
303 Joshi P, Katsushima K, Zhou R, Meoded A, Stapleton S, Jallo G, Raabe E, Eberhart CG, Perera RJ. The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma. Neurooncol Adv 2019;1:vdz023. [PMID: 31763623 DOI: 10.1093/noajnl/vdz023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
304 Kirchner A, Dachet F, Loeb JA. Identifying targets for preventing epilepsy using systems biology of the human brain. Neuropharmacology 2020;168:107757. [PMID: 31493467 DOI: 10.1016/j.neuropharm.2019.107757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
305 Abdalla MOA, Yamamoto T, Maehara K, Nogami J, Ohkawa Y, Miura H, Poonperm R, Hiratani I, Nakayama H, Nakao M, Saitoh N. The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis. Nat Commun 2019;10:3778. [PMID: 31439835 DOI: 10.1038/s41467-019-11378-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
306 Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, Tang Y. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer 2019;19:779. [PMID: 31391008 DOI: 10.1186/s12885-019-5983-8] [Cited by in Crossref: 132] [Cited by in F6Publishing: 147] [Article Influence: 33.0] [Reference Citation Analysis]
307 Luo T, Chen M, Zhao Y, Wang D, Liu J, Chen J, Luo H, Li L. Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma. Onco Targets Ther 2019;12:6203-16. [PMID: 31498334 DOI: 10.2147/OTT.S213833] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
308 Gomes CP, Nóbrega-Pereira S, Domingues-Silva B, Rebelo K, Alves-Vale C, Marinho SP, Carvalho T, Dias S, Bernardes de Jesus B. An antisense transcript mediates MALAT1 response in human breast cancer. BMC Cancer 2019;19:771. [PMID: 31382922 DOI: 10.1186/s12885-019-5962-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
309 West KA, Lagos D. Long Non-Coding RNA Function in CD4+ T Cells: What We Know and What Next? Noncoding RNA 2019;5:E43. [PMID: 31336952 DOI: 10.3390/ncrna5030043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
310 Luo K, Geng J, Zhang Q, Xu Y, Zhou X, Huang Z, Shi KQ, Pan C, Wu J. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer. J Exp Clin Cancer Res 2019;38:249. [PMID: 31186036 DOI: 10.1186/s13046-019-1263-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 15.0] [Reference Citation Analysis]
311 Yamamoto T, Saitoh N. Non-coding RNAs and chromatin domains. Current Opinion in Cell Biology 2019;58:26-33. [DOI: 10.1016/j.ceb.2018.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
312 Yang J, Wang X. Role of long non-coding RNAs in lymphoma: A systematic review and clinical perspectives. Crit Rev Oncol Hematol 2019;141:13-22. [PMID: 31202125 DOI: 10.1016/j.critrevonc.2019.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
313 Suriyamurthy S, Baker D, Ten Dijke P, Iyengar PV. Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer. Cancers (Basel) 2019;11:E726. [PMID: 31137748 DOI: 10.3390/cancers11050726] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
314 Yonkunas MJ, Baird NJ. A highly ordered, nonprotective MALAT1 ENE structure is adopted prior to triplex formation. RNA 2019;25:975-84. [PMID: 31113838 DOI: 10.1261/rna.069906.118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
315 Arjmand F, Afsan Z, Sharma S, Parveen S, Yousuf I, Sartaj S, Siddique HR, Tabassum S. Recent advances in metallodrug-like molecules targeting non-coding RNAs in cancer chemotherapy. Coordination Chemistry Reviews 2019;387:47-59. [DOI: 10.1016/j.ccr.2019.02.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
316 Rossi M, Bucci G, Rizzotto D, Bordo D, Marzi MJ, Puppo M, Flinois A, Spadaro D, Citi S, Emionite L, Cilli M, Nicassio F, Inga A, Briata P, Gherzi R. LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β. Nat Commun 2019;10:1969. [PMID: 31036808 DOI: 10.1038/s41467-019-09754-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
317 Gugnoni M, Ciarrocchi A. Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer. Int J Mol Sci 2019;20:E1924. [PMID: 31003545 DOI: 10.3390/ijms20081924] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 22.3] [Reference Citation Analysis]
318 Esposito R, Bosch N, Lanzós A, Polidori T, Pulido-quetglas C, Johnson R. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening. Cancer Cell 2019;35:545-57. [DOI: 10.1016/j.ccell.2019.01.019] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 26.8] [Reference Citation Analysis]
319 Yerukala Sathipati S, Sahu D, Huang HC, Lin Y, Ho SY. Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma. Sci Rep 2019;9:5125. [PMID: 30914706 DOI: 10.1038/s41598-019-41553-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
320 Arun G, Spector DL. MALAT1 Long non-coding RNA and breast cancer. RNA Biol. 2019;16:860-863. [PMID: 30874469 DOI: 10.1080/15476286.2019.1592072] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 13.8] [Reference Citation Analysis]
321 Gu X, Wang L, Boldrup L, Coates PJ, Fahraeus R, Sgaramella N, Wilms T, Nylander K. AP001056.1, A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck. Cancers (Basel) 2019;11:E347. [PMID: 30862109 DOI: 10.3390/cancers11030347] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
322 Léveillé N, Baglio SR. Exosome-transferred lncRNAs at the core of cancer bone lesions. Crit Rev Oncol Hematol 2019;139:125-7. [PMID: 30890387 DOI: 10.1016/j.critrevonc.2019.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
323 Barr JA, Hayes KE, Brownmiller T, Harold AD, Jagannathan R, Lockman PR, Khan S, Martinez I. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells. Sci Rep 2019;9:3662. [PMID: 30842470 DOI: 10.1038/s41598-019-40094-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
324 Dong P, Xiong Y, Yue J, J B Hanley S, Kobayashi N, Todo Y, Watari H. Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges. Cancers (Basel) 2019;11:E234. [PMID: 30781521 DOI: 10.3390/cancers11020234] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 12.3] [Reference Citation Analysis]
325 Nie D, Fu J, Chen H, Cheng J, Fu J. Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential. Int J Mol Sci 2019;20:E861. [PMID: 30781524 DOI: 10.3390/ijms20040861] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
326 Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, Schneekloth JS Jr, Dayie TK, Spector D, Baird N, Le Grice SFJ. Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1. ACS Chem Biol 2019;14:223-35. [PMID: 30620551 DOI: 10.1021/acschembio.8b00807] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 20.8] [Reference Citation Analysis]
327 Beltrán-Anaya FO, Romero-Córdoba S, Rebollar-Vega R, Arrieta O, Bautista-Piña V, Dominguez-Reyes C, Villegas-Carlos F, Tenorio-Torres A, Alfaro-Riuz L, Jiménez-Morales S, Cedro-Tanda A, Ríos-Romero M, Reyes-Grajeda JP, Tagliabue E, Iorio MV, Hidalgo-Miranda A. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death. Mol Oncol 2019;13:909-27. [PMID: 30648789 DOI: 10.1002/1878-0261.12446] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
328 Li Y, Egranov SD, Yang L, Lin C. Molecular mechanisms of long noncoding RNAs‐mediated cancer metastasis. Genes Chromosomes Cancer 2019;58:200-7. [DOI: 10.1002/gcc.22691] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 12.5] [Reference Citation Analysis]
329 Wang S, Lv Y, Xu X, Zuo Y, Song Y, Wu G, Lu P, Zhang Z, Chen M. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling. Cancer Letters 2019;443:13-24. [DOI: 10.1016/j.canlet.2018.11.028] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
330 Miranda-Castro R, de-Los-Santos-Álvarez N, Lobo-Castañón MJ. Long noncoding RNAs: from genomic junk to rising stars in the early detection of cancer. Anal Bioanal Chem 2019;411:4265-75. [PMID: 30683966 DOI: 10.1007/s00216-019-01607-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
331 Barman P, Reddy D, Bhaumik SR. Mechanisms of Antisense Transcription Initiation with Implications in Gene Expression, Genomic Integrity and Disease Pathogenesis. Noncoding RNA 2019;5:E11. [PMID: 30669611 DOI: 10.3390/ncrna5010011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
332 Lorenzi L, Avila Cobos F, Decock A, Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ, Speleman F, Vandesompele J, Mestdagh P. Long noncoding RNA expression profiling in cancer: Challenges and opportunities. Genes Chromosomes Cancer. 2019;58:191-199. [PMID: 30461116 DOI: 10.1002/gcc.22709] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 21.3] [Reference Citation Analysis]
333 Deng M, Yuan H, Liu S, Hu Z, Xiao H. Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression. Cytotherapy 2019;21:96-106. [DOI: 10.1016/j.jcyt.2018.10.006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 63] [Article Influence: 13.5] [Reference Citation Analysis]
334 Torsin LI, Dragomir MP, Calin GA. New Insights into the Molecular Mechanisms of Long Non-coding RNAs in Cancer Biology. Molecular Biology of Long Non-coding RNAs 2019. [DOI: 10.1007/978-3-030-17086-8_4] [Reference Citation Analysis]
335 You C, Zhu K, Zhang Q, Yan J, Wang Y, Li J. ODNA: a manually curated database of noncoding RNAs associated with orthopedics. Database (Oxford) 2019;2019:baz126. [PMID: 31781773 DOI: 10.1093/database/baz126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
336 Chi S, Liu Y, Zhou X, Feng D, Xiao X, Li W, Zhao Y, Wang H. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B. Cancer Chemother Pharmacol 2019;83:277-87. [DOI: 10.1007/s00280-018-3727-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
337 Donato L, Scimone C, Rinaldi C, D'Angelo R, Sidoti A. Non-coding RNAome of RPE cells under oxidative stress suggests unknown regulative aspects of Retinitis pigmentosa etiopathogenesis. Sci Rep 2018;8:16638. [PMID: 30413775 DOI: 10.1038/s41598-018-35086-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
338 Zhang S, Guan Y, Liu X, Ju M, Zhang Q. Long non-coding RNA DLEU1 exerts an oncogenic function in non-small cell lung cancer. Biomed Pharmacother 2019;109:985-90. [PMID: 30551552 DOI: 10.1016/j.biopha.2018.10.175] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
339 Song W, Miao DL, Chen L. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma. Biochem Biophys Res Commun 2018;506:1004-12. [PMID: 30404735 DOI: 10.1016/j.bbrc.2018.10.186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
340 Pederson T. Nuclear Bodies Toward Human Bodies. FASEB J 2018;32:5761-3. [PMID: 30376379 DOI: 10.1096/fj.181101ufm] [Reference Citation Analysis]
341 Li Z, Li X, Chen X, Li S, Ho IHT, Liu X, Chan MTV, Wu WKK. Emerging roles of long non-coding RNAs in neuropathic pain. Cell Prolif 2019;52:e12528. [PMID: 30362191 DOI: 10.1111/cpr.12528] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
342 Dong P, Xiong Y, Yue J, Hanley SJB, Kobayashi N, Todo Y, Watari H. Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors. Front Genet. 2018;9:471. [PMID: 30374364 DOI: 10.3389/fgene.2018.00471] [Cited by in Crossref: 122] [Cited by in F6Publishing: 130] [Article Influence: 24.4] [Reference Citation Analysis]
343 Falcone C, Mazzoni C. RNA stability and metabolism in regulated cell death, aging and diseases. FEMS Yeast Research 2018;18. [DOI: 10.1093/femsyr/foy050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]